In addition, IFC-305, an adenosine derivative, inhibits methylation of the PPARγ promoter and up-regulates PPARγ expression, thereby reducing the risk of radiation-induced intestinal toxicity in colon cancer treatment [100]. The gene discussed is PPARG; the disease is colonic neoplasm.